Advertisement
Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin's lymphoma drug Rituxan

FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug

0
Truxima approved to treat adults with CD20-positive, B-cell non-Hodgkin's lymphoma
From 2007 to 2016

Pregnancy-Associated Mortality Involving Opioids Up

0
Between 2007 and 2016, pregnancy-associated mortality related to opioids more than doubled
Among older patients with polycythemia vera

Recommended Therapies for Polycythemia Vera Underused

0
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients
Participation in the Supplemental Nutrition Assistance Program may reduce the number of low-income older adults with diabetes forgoing medications because of cost

Food Assistance May Help Older Adults Adhere to Diabetes Meds

0
Food assistance may cut number of older adults with diabetes forgoing medications due to cost
For older adults with dementia

Risks of Trazodone Similar to Those of Atypical Antipsychotics

0
Among older adults with dementia, rates of falls, fracture similar, but mortality rate lower
A major update of the United States' system for approving medical devices was announced yesterday by the Food and Drug Administration.

FDA to Update Medical Device Approvals Process

0
Revised process will ensure new medical devices meet safety and effectiveness standards
The U.S. Food and Drug Administration is warning men that "Rhino" products promising better sex may pose serious health risks.

Men Should Avoid ‘Rhino’ Sexual Enhancement Products, FDA Says

0
Reports include chest pain, severe headaches, prolonged erections after taking Rhino products
Vitrakvi (larotrectinib) has been approved by the U.S. Food and Drug Administration to treat adult and pediatric patients whose cancers have a specific genetic feature.

FDA Approves Vitrakvi for Cancers With Certain Genetic Trait

0
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
Ebola infections in newborns are being reported in the current outbreak of the deadly disease in Congo

Newborns Infected With Ebola in Congo Outbreak

0
Seven cases seen in newborn babies and infants younger than 2 years old
The U.S. Food and Drug Administration recently announced the approval of Daurismo (glasdegib) tablets for use in combination with a low dose of the chemotherapy cytarabine to treat newly diagnosed acute myeloid leukemia. The treatment is indicated for patients aged 75 years or older who have comorbidities that may prevent the use of intensive chemotherapy.

FDA Approves New Treatment for Acute Myeloid Leukemia

0
Randomized clinical trial showed significant improvement in overall survival with Daurismo